NCT01997424

Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 340 (actual)
• Sponsor: Johann Wolfgang Goethe University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the association of non-alcoholic fatty liver disease and diabetes mellitus. Patients presenting in our clinic with Diabetes mellitus type 1 or 2 will receive the following examination: * Transient Elastography and Controlled Attenuation Parameter using the FibroScan * blood examination including biochemical markers The statistically calculated sample size needed is 340 patients.

Conditions

• Non-alcoholic Fatty Liver Disease (NAFLD)

Interventions

Type	Name	Description
DEVICE	Controlled Attenuation Parameter (CAP), Echosens, Paris, France
DEVICE	FibroScan, Echosens, Paris, France

Timeline

• Start date: 2013-05-01
• Primary completion: 2019-12-31
• Completion: 2019-12-31
• First posted: 2013-11-28
• Last updated: 2021-02-03

Locations

1 site across 1 country: Germany